Search Results - "Sato, Aaron K"

Refine Results
  1. 1
  2. 2

    Discovery of a potent, selective, and tumor-suppressing antibody antagonist of adenosine A2A receptor by Wang, Linya, Garg, Pankaj, Chan, Kara Y, Yuan, Tom Z, Lujan Hernandez, Ana G, Han, Zhen, Peterson, Sean M, Tuscano, Emily, Safavi, Crystal, Kwan, Eric, Villalta, Mouna, Mathur, Melina, Lai, Joyce, Axelrod, Fumiko, Souders, Colby A, Emery, Chloe, Sato, Aaron K

    Published in PloS one (2024)
    “…New immune checkpoints are emerging in a bid to improve response rates to immunotherapeutic drugs. The adenosine A2A receptor (A2AR) has been proposed as a…”
    Get full text
    Journal Article
  3. 3

    Discovery and design of G protein-coupled receptor targeting antibodies by Peterson, Sean M, Hutchings, Catherine J, Hu, Cameron F, Mathur, Melina, Salameh, Janelle W, Axelrod, Fumiko, Sato, Aaron K

    Published in Expert opinion on drug discovery (03-04-2023)
    “…G protein-coupled receptors (GPCRs) are the target of one-third of all approved drugs; however, these drugs only target about one-eighth of the human…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Functional GLP-1R antibodies identified from a synthetic GPCR-focused library demonstrate potent blood glucose control by Liu, Qiang, Garg, Pankaj, Hasdemir, Burcu, Wang, Linya, Tuscano, Emily, Sever, Emily, Keane, Erica, Hernandez, Ana G Lujan, Yuan, Tom Z, Kwan, Eric, Lai, Joyce, Szot, Greg, Paruthiyil, Sreenivasan, Axelrod, Fumiko, K Sato, Aaron

    Published in mAbs (01-01-2021)
    “…G protein-coupled receptors (GPCRs) are a group of seven-transmembrane receptor proteins that have proven to be successful drug targets. Antibodies are…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Engineering toward a bacterial "endoplasmic reticulum" for the rapid expression of immunoglobulin proteins by Groff, Dan, Armstrong, Stephanie, Rivers, Patrick J, Zhang, Juan, Yang, Junhao, Green, Evan, Rozzelle, James, Liang, Shengwen, Kittle, Joseph D, Steiner, Alexander R, Baliga, Ramesh, Thanos, Christopher D, Hallam, Trevor J, Sato, Aaron K, Yam, Alice Y

    Published in mAbs (01-05-2014)
    “…Antibodies are well-established as therapeutics, and the preclinical and clinical pipeline of these important biologics is growing rapidly. Consequently, there…”
    Get full text
    Journal Article
  8. 8

    Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail by Froude, Jeffrey W, Herbert, Andrew S, Pelat, Thibaut, Miethe, Sebastian, Zak, Samantha E, Brannan, Jennifer M, Bakken, Russell R, Steiner, Alexander R, Yin, Gang, Hallam, Trevor J, Sato, Aaron K, Hust, Michael, Thullier, Philippe, Dye, John M

    Published in Viruses (26-05-2018)
    “…Sudan virus (SUDV) and Ebola viruses (EBOV) are both members of the genus and have been sources of epidemics and outbreaks for several decades. We present here…”
    Get full text
    Journal Article
  9. 9

    Discovery of Fully Human Anti-MET Monoclonal Antibodies with Antitumor Activity against Colon Cancer Tumor Models In Vivo by van der Horst, Edward Htun, Chinn, Lawrence, Wang, Min, Velilla, Timothy, Tran, Hoang, Madrona, Yarrow, Lam, Andrew, Ji, May, Hoey, Timothy C., Sato, Aaron K.

    Published in Neoplasia (New York, N.Y.) (01-04-2009)
    “…The receptor tyrosine kinase MET is a major component controlling the invasive growth program in embryonic development and in invasive malignancies. The…”
    Get full text
    Journal Article
  10. 10

    Phage display technology and its impact in the discovery of novel protein-based drugs by Hutchings, Catherine J, Sato, Aaron K

    Published in Expert opinion on drug discovery (02-08-2024)
    “…Phage display technology is a well-established versatile display technology that has been used for over 35 years to identify peptides and antibodies for use as…”
    Get more information
    Journal Article
  11. 11

    Therapeutic peptides: technological advances driving peptides into development by Sato, Aaron K, Viswanathan, Malini, Kent, Rachel B, Wood, Clive R

    Published in Current opinion in biotechnology (01-12-2006)
    “…As potential therapeutics, peptides offer several advantages over small molecules (increased specificity) and antibodies (small size). Nevertheless, a number…”
    Get full text
    Journal Article
  12. 12

    Methods to Make Homogenous Antibody Drug Conjugates by Kline, Toni, Steiner, Alexander R., Penta, Kalyani, Sato, Aaron K., Hallam, Trevor J., Yin, Gang

    Published in Pharmaceutical research (01-11-2015)
    “…Antibody drug conjugates (ADCs) have progressed from hypothesis to approved therapeutics in less than 30 years, and the technologies available to modify both…”
    Get full text
    Journal Article
  13. 13

    Extracellular Antigen Processing and Presentation by Immature Dendritic Cells by Santambrogio, Laura, Sato, Aaron K., Carven, Gregory J., Belyanskaya, Svetlana L., Strominger, Jack L., Stern, Lawrence J.

    “…In antigen presentation to CD4+T cells, proteins are degraded to peptide fragments and loaded onto class II MHC molecules in a process involving the peptide…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Abundant Empty Class II MHC Molecules on the Surface of Immature Dendritic Cells by Santambrogio, Laura, Sato, Aaron K., Fischer, Falko R., Dorf, Martin E., Stern, Lawrence J.

    “…A monoclonal antibody specific for the empty conformation of class II MHC molecules revealed the presence of abundant empty molecules on the surface of spleen-…”
    Get full text
    Journal Article
  17. 17

    Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission by Kapoor, Neeraj, Vanjak, Ivana, Rozzelle, James, Berges, Aym, Chan, Wei, Yin, Gang, Tran, Cuong, Sato, Aaron K, Steiner, Alexander R, Pham, Thao P, Birkett, Ashley J, Long, Carole A, Fairman, Jeff, Miura, Kazutoyo

    Published in Biochemistry (Easton) (06-02-2018)
    “…Malaria, one of the most common vector borne human diseases, is a major world health issue. In 2015 alone, more than 200 million people were infected with…”
    Get full text
    Journal Article
  18. 18
  19. 19

    A simplified and robust protocol for immunoglobulin expression in Escherichia coli cell-free protein synthesis systems by Cai, Qi, Hanson, Jeffrey A., Steiner, Alexander R., Tran, Cuong, Masikat, Mary Rose, Chen, Rishard, Zawada, James F., Sato, Aaron K., Hallam, Trevor J., Yin, Gang

    Published in Biotechnology progress (01-05-2015)
    “…Cell‐free protein synthesis (CFPS) systems allow for robust protein expression with easy manipulation of conditions to improve protein yield and folding…”
    Get full text
    Journal Article
  20. 20

    Toward a Ferrous Iron-Cleavable Linker for Antibody–Drug Conjugates by Spangler, Benjamin, Kline, Toni, Hanson, Jeffrey, Li, Xiaofan, Zhou, Sihong, Wells, James A, Sato, Aaron K, Renslo, Adam R

    Published in Molecular pharmaceutics (07-05-2018)
    “…Antibody–drug conjugates (ADCs) are antigen-targeted therapeutics that employ antibodies to deliver potent, cytotoxic effectors to cells with potentially high…”
    Get full text
    Journal Article